Tadashi Uwagawa

Author PubWeight™ 20.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol 2004 1.96
2 Intrahepatic cholangiocarcinoma mimicking hepatic inflammatory pseudotumor. J Gastrointest Surg 2007 0.97
3 Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. Cancer 2005 0.97
4 Successful treatment of advanced gallbladder cancer with an anticancer drug S-1: assessment based on intratumoral gene. Int J Clin Oncol 2008 0.96
5 Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response. J Biol Chem 2005 0.91
6 Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse model. Oncol Rep 2010 0.85
7 Systemic inflammatory response syndrome after hand-assisted laparoscopic distal pancreatectomy. Surg Endosc 2007 0.84
8 Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition. J Hepatobiliary Pancreat Sci 2011 0.84
9 Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice. J Am Coll Surg 2012 0.83
10 Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice. Cancer Lett 2011 0.82
11 Hydroxyurea decreases gemcitabine resistance in pancreatic carcinoma cells with highly expressed ribonucleotide reductase. Pancreas 2012 0.82
12 Nuclear factor κB activity correlates with the progression and prognosis of pancreatic cancer in a mouse model. Surg Today 2012 0.81
13 Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer. Cancer Lett 2013 0.81
14 Assessment of blood-products use as predictor of pulmonary complications and surgical-site infection after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2008 0.80
15 Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation. J Surg Res 2013 0.80
16 Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice. Dig Dis Sci 2012 0.80
17 Combination paclitaxel and inhibitor of nuclear factor κB activation improves therapeutic outcome for model mice with peritoneal dissemination of pancreatic cancer. Pancreas 2011 0.79
18 Safe and quick distal pancreatectomy using a staggered six-row stapler. Am J Surg 2008 0.79
19 Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycytidine kinase? Oncol Rep 2010 0.78
20 Prognostic factors of unresectable pancreatic cancer treated with nafamostat mesilate combined with gemcitabine chemotherapy. Anticancer Res 2012 0.78
21 Analysis of bile duct injuries (Stewart-Way classification) during laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg 2006 0.78
22 Inhibition of nuclear factor-κB enhances the antitumor effect of tumor necrosis factor-α gene therapy for hepatocellular carcinoma in mice. Surgery 2013 0.78
23 Technical and mechanical risk factors for postoperative pancreatic fistula in pancreaticojejunostomy. Hepatogastroenterology 2011 0.77
24 Radical Resection of a Primarily Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy Using Gemcitabine, TS-1, and Nafamostat Mesilate; Report of a Case. Int Surg 2015 0.75
25 [Usefulness of epidural catheter with the subcutaneous reservoir for cancer pain control in homecare service]. Gan To Kagaku Ryoho 2011 0.75
26 [The current status of home palliative care for patients with advanced cancer at the Jikei University School of Medicine]. Gan To Kagaku Ryoho 2014 0.75
27 [A case of stage IV b pancreatic cancer in which a catheter-related infection caused by epidural/subcutaneous reservoir therapy affected palliative home-based care]. Gan To Kagaku Ryoho 2012 0.75